BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36286226)

  • 1. Sequence-Based Identification of Metronidazole-Resistant Clostridioides difficile Isolates.
    Smits WK; Harmanus C; Sanders IMJG; Bry L; Blackwell GA; Ducarmon QR; de Oliveira Ferreira E; Kuijper EJ
    Emerg Infect Dis; 2022 Nov; 28(11):2308-2311. PubMed ID: 36286226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Plasmid-Mediated Resistance to Metronidazole in Clostridioides difficile from River Water.
    Cizek A; Masarikova M; Mares J; Brajerova M; Krutova M
    Microbiol Spectr; 2022 Aug; 10(4):e0080622. PubMed ID: 35950844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile.
    Boekhoud IM; Sidorov I; Nooij S; Harmanus C; Bos-Sanders IMJG; Viprey V; Spittal W; Clark E; Davies K; Freeman J; Kuijper EJ; Smits WK;
    J Antimicrob Chemother; 2021 Jun; 76(7):1731-1740. PubMed ID: 33876817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid-mediated metronidazole resistance in Clostridioides difficile.
    Boekhoud IM; Hornung BVH; Sevilla E; Harmanus C; Bos-Sanders IMJG; Terveer EM; Bolea R; Corver J; Kuijper EJ; Smits WK
    Nat Commun; 2020 Jan; 11(1):598. PubMed ID: 32001686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences.
    Kolte B; Nübel U
    J Antimicrob Chemother; 2024 Jun; 79(6):1320-1328. PubMed ID: 38598696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of Circulating
    Martínez-Meléndez A; Tijerina-Rodríguez L; Collins N; Baines SD; Morfin-Otero R; Camacho-Ortíz A; Villarreal-Treviño L; Garza-González E
    Microb Drug Resist; 2021 Dec; 27(12):1672-1676. PubMed ID: 34037477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of
    Alves F; Castro R; Pinto M; Nunes A; Pomba C; Oliveira M; Silveira L; Gomes JP; Oleastro M
    Front Public Health; 2022; 10():1070258. PubMed ID: 36684930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental contamination with Clostridioides (Clostridium) difficile in Vietnam.
    Khun PA; Phi LD; Bui HTT; Bui NT; Vu QTH; Trinh LD; Collins DA; Riley TV
    J Appl Microbiol; 2023 Jun; 134(6):. PubMed ID: 37296244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, genetic characteristics, and antimicrobial resistance of Clostridioides difficile isolates from horses in Korea.
    Lee YR; Lee K; Byun JW; Kim H; So B; Ku BK; Kim HY; Moon BY
    Anaerobe; 2023 Apr; 80():102700. PubMed ID: 36716814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology and antimicrobial resistance patterns of Clostridioides difficile isolates in Algerian hospitals.
    Boudjelal Y; Krutova M; Djebbar A; Sebaihia M; Bekara MEA; Rouabhia S; Couturier J; Syed-Zaidi R; Barbut F
    J Infect Dev Ctries; 2022 Jun; 16(6):1055-1063. PubMed ID: 35797301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dogs as carriers of virulent and resistant genotypes of Clostridioides difficile.
    Finsterwalder SK; Loncaric I; Cabal A; Szostak MP; Barf LM; Marz M; Allerberger F; Burgener IA; Tichy A; Feßler AT; Schwarz S; Monecke S; Ehricht R; Ruppitsch W; Spergser J; Künzel F
    Zoonoses Public Health; 2022 Sep; 69(6):673-681. PubMed ID: 35546073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A narrative review of Clostridioides difficile infection in China.
    Wu Y; Wang YY; Bai LL; Zhang WZ; Li GW; Lu JX
    Anaerobe; 2022 Apr; 74():102540. PubMed ID: 35219837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Clostridioides difficile in dogs (Canis familiaris) with gastrointestinal disorders in Rio de Janeiro.
    Leite S; Cotias C; Rainha KC; Santos MG; Penna B; F Moraes RF; Harmanus C; Smits WK; Ferreira EO
    Anaerobe; 2023 Oct; 83():102765. PubMed ID: 37573963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribotypes and antimicrobial susceptibility profiles of clinical Clostridioides difficile isolates: A multicenter, laboratory-based surveillance in Taiwan, 2019-2021.
    Tsai CS; Lu PL; Lu MC; Hsieh TC; Chen WT; Wang JT; Ko WC
    J Microbiol Immunol Infect; 2024 Apr; 57(2):320-327. PubMed ID: 38135646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Clostridioides difficile isolates recovered from two Phase 3 surotomycin treatment trials by restriction endonuclease analysis, PCR ribotyping and antimicrobial susceptibilities.
    Cheknis A; Devaris D; Chesnel L; Dale SE; Nary J; Sambol SP; Citron DM; Goering RV; Johnson S
    J Antimicrob Chemother; 2020 Nov; 75(11):3120-3125. PubMed ID: 32747931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A US-based national surveillance study for the susceptibility and epidemiology of
    Snydman DR; McDermott LA; Thorpe CM; Goldstein EJC; Schuetz AN; Johnson S; Gerding DN; Gluck L; Bourdas D; Carroll KC; Lancaster CK; Garey KW; Wang Q; Walk ST; Duperchy E
    Antimicrob Agents Chemother; 2023 Oct; 67(10):e0034923. PubMed ID: 37728368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronidazole-resistant Clostridioides difficile: genomic and transcriptomic traits acquired under in-vitro metronidazole induction.
    Xu T; Zhou F; Wang L; Wu S; Huang H
    Int J Antimicrob Agents; 2022 May; 59(5):106570. PubMed ID: 35296432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17.
    Gargis AS; Karlsson M; Paulick AL; Anderson KF; Adamczyk M; Vlachos N; Kent AG; McAllister G; McKay SL; Halpin AL; Albrecht V; Campbell D; Korhonen LC; Elkins CA; Rasheed JK; Guh AY; McDonald LC; Lutgring JD;
    Clin Infect Dis; 2023 Mar; 76(5):890-896. PubMed ID: 36208202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone resistance and Clostridium difficile, Germany.
    Zaiss NH; Witte W; Nübel U
    Emerg Infect Dis; 2010 Apr; 16(4):675-7. PubMed ID: 20350385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.
    Karlowsky JA; Adam HJ; Baxter MR; Dutka CW; Nichol KA; Laing NM; Golding GR; Zhanel GG
    J Antimicrob Chemother; 2020 Jul; 75(7):1824-1832. PubMed ID: 32294172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.